1
|
Wu J, Cheng X, Wu J, Chen J, Pei X. The development of magnesium-based biomaterials in bone tissue engineering: A review. J Biomed Mater Res B Appl Biomater 2024; 112:e35326. [PMID: 37861271 DOI: 10.1002/jbm.b.35326] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Revised: 07/15/2023] [Accepted: 08/23/2023] [Indexed: 10/21/2023]
Abstract
Bone regeneration is a vital clinical challenge in massive or complicated bone defects. Recently, bone tissue engineering has come to the fore to meet the demand for bone repair with various innovative materials. However, the reported materials usually cannot satisfy the requirements, such as ideal mechanical and osteogenic properties, as well as biocompatibility at the same time. Mg-based biomaterials have considerable potential in bone tissue engineering owing to their excellent mechanical strength and biosafety. Moreover, the biocompatibility and osteogenic activity of Mg-based biomaterials have been the research focuses in recent years. The main limitation faced in the applications of Mg-based biomaterials is rapid degradation, which can produce excessive Mg2+ and hydrogen, affecting the healing of the bone defect. In order to overcome the limitations, researchers have explored several ways to improve the properties of Mg-based biomaterials, including alloying, surface modification with coatings, and synthesizing other composite materials to control the degradation rate upon implantation. This article reviewed the osteogenic mechanism and requirement for appropriate degradation rate and focused on current progress in the biomedical use of Mg-based biomaterials to inspire more clinical applications of Mg in bone regeneration in the future.
Collapse
Affiliation(s)
- Jiaxin Wu
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China
| | - Xinting Cheng
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China
| | - Jicenyuan Wu
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China
| | - Junyu Chen
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China
| | - Xibo Pei
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China
| |
Collapse
|
2
|
Zhang M, Wang Z, Zhang A, Liu L, Mithieux SM, Bilek MMM, Weiss AS. Development of tropoelastin-functionalized anisotropic PCL scaffolds for musculoskeletal tissue engineering. Regen Biomater 2022; 10:rbac087. [PMID: 36683733 PMCID: PMC9845519 DOI: 10.1093/rb/rbac087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 09/08/2022] [Accepted: 10/08/2022] [Indexed: 01/25/2023] Open
Abstract
The highly organized extracellular matrix (ECM) of musculoskeletal tissues, encompassing tendons, ligaments and muscles, is structurally anisotropic, hierarchical and multi-compartmental. These features collectively contribute to their unique function. Previous studies have investigated the effect of tissue-engineered scaffold anisotropy on cell morphology and organization for musculoskeletal tissue repair and regeneration, but the hierarchical arrangement of ECM and compartmentalization are not typically replicated. Here, we present a method for multi-compartmental scaffold design that allows for physical mimicry of the spatial architecture of musculoskeletal tissue in regenerative medicine. This design is based on an ECM-inspired macromolecule scaffold. Polycaprolactone (PCL) scaffolds were fabricated with aligned fibers by electrospinning and mechanical stretching, and then surface-functionalized with the cell-supporting ECM protein molecule, tropoelastin (TE). TE was attached using two alternative methods that allowed for either physisorption or covalent attachment, where the latter was achieved by plasma ion immersion implantation (PIII). Aligned fibers stimulated cell elongation and improved cell alignment, in contrast to randomly oriented fibers. TE coatings bound by physisorption or covalently following 200 s PIII treatment promoted fibroblast proliferation. This represents the first cytocompatibility assessment of novel PIII-treated TE-coated PCL scaffolds. To demonstrate their versatility, these 2D anisotropic PCL scaffolds were assembled into 3D hierarchical constructs with an internally compartmentalized structure to mimic the structure of musculoskeletal tissue.
Collapse
Affiliation(s)
- Miao Zhang
- Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia,School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia
| | - Ziyu Wang
- Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia,School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia
| | - Anyu Zhang
- Applied and Plasma Physics Laboratory, School of Physics, The University of Sydney, Sydney, NSW 2006, Australia,School of Biomedical Engineering, The University of Sydney, Sydney, NSW 2006, Australia
| | - Linyang Liu
- Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia,School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia
| | - Suzanne M Mithieux
- Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia,School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia
| | - Marcela M M Bilek
- Applied and Plasma Physics Laboratory, School of Physics, The University of Sydney, Sydney, NSW 2006, Australia,School of Biomedical Engineering, The University of Sydney, Sydney, NSW 2006, Australia
| | | |
Collapse
|
3
|
Li L, Areson C, van der Straten A, Johnson LM. Effects of Polymer Blending on the Performance of a Subcutaneous Biodegradable Implant for HIV Pre-Exposure Prophylaxis (PrEP). Int J Mol Sci 2021; 22:ijms22126529. [PMID: 34207212 PMCID: PMC8235439 DOI: 10.3390/ijms22126529] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Revised: 06/04/2021] [Accepted: 06/13/2021] [Indexed: 12/16/2022] Open
Abstract
Long-acting (LA) HIV pre-exposure prophylaxis (PrEP) can mitigate challenges of adhering to daily or on-demand regimens of antiretrovirals (ARVs). We are developing a subcutaneous implant comprising polycaprolactone (PCL) for sustained delivery of ARVs for PrEP. Here we use tenofovir alafenamide (TAF) as a model drug. Previously, we demonstrated that the release rates of drugs are controlled by the implant surface area and wall thickness, and the molecular weight (MW) of PCL. Here, we further advance the implant design and tailor the release rates of TAF and the mechanical integrity of the implant through unique polymer blend formulations. In vitro release of TAF from the implant exhibited zero-order release kinetics for ~120 days. TAF release rates were readily controlled via the MW of the polymer blend, with PCL formulations of higher MW releasing the drug faster than implants with lower MW PCL. Use of polymer MW to tune drug release rates is partly explained by PCL crystallinity, as higher PCL crystalline material is often associated with a slower release rate. Moreover, results showed the ability to tailor mechanical properties via PCL blends. Blending PCL offers an effective approach for tuning the ARV release rates, implant duration, and integrity, and ultimately the biodegradation profiles of the implant.
Collapse
Affiliation(s)
- Linying Li
- Engineered Systems RTI International, Durham, NC 27709, USA; (L.L.); (C.A.)
| | - Christine Areson
- Engineered Systems RTI International, Durham, NC 27709, USA; (L.L.); (C.A.)
| | - Ariane van der Straten
- Center for AIDS Prevention Studies, Department of Medicine, University of California San Francisco, San Francisco, CA 94104, USA;
- ASTRA Consulting, Kensington, CA 94708, USA
| | - Leah M. Johnson
- Engineered Systems RTI International, Durham, NC 27709, USA; (L.L.); (C.A.)
- Correspondence: ; Tel.: +1-919-541-7233
| |
Collapse
|
4
|
Alavi SK, Lotz O, Akhavan B, Yeo G, Walia R, McKenzie DR, Bilek MM. Atmospheric Pressure Plasma Jet Treatment of Polymers Enables Reagent-Free Covalent Attachment of Biomolecules for Bioprinting. ACS APPLIED MATERIALS & INTERFACES 2020; 12:38730-38743. [PMID: 32706575 DOI: 10.1021/acsami.0c07169] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Three-dimensional (3D) bioprinting, where cells, hydrogels, and structural polymers can be printed layer by layer into complex designs, holds great promise for advances in medicine and the biomedical sciences. In principle, this technique enables the creation of highly patient-specific disease models and biomedical implants. However, an ability to tailor surface biocompatibility and interfacial bonding between printed components, such as polymers and hydrogels, is currently lacking. Here we demonstrate that an atmospheric pressure plasma jet (APPJ) can locally activate polymeric surfaces for the reagent-free covalent attachment of proteins and hydrogel in a single-step process at desired locations. Polyethylene and poly-ε-caprolactone were used as example polymers. Covalent attachment of the proteins and hydrogel was demonstrated by resistance to removal by rigorous sodium dodecyl sulfate washing. The immobilized protein and hydrogel layers were analyzed using Fourier transform infrared and X-ray photoelectron spectroscopy. Importantly, the APPJ surface activation also rendered the polymer surfaces mildly hydrophilic as required for optimum biocompatibility. Water contact angles were observed to be stable within a range where the conformation of biomolecules is preserved. Single and double electrode designs of APPJs were compared in their characteristics relevant to localized surface functionalization, plume length, and shape. As a proof of efficacy in a biological context, APPJ-treated polyethylene functionalized with fibronectin was used to demonstrate improvements in cell adhesion and proliferation. These results have important implications for the development of a new generation of 3D bioprinters capable of spatially patterned and tailored surface functionalization performed during the 3D printing process in situ.
Collapse
Affiliation(s)
| | - Oliver Lotz
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
- School of Biomedical Engineering, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - Behnam Akhavan
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
- School of Biomedical Engineering, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - Giselle Yeo
- Charles Perkins Centre, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - Rashi Walia
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - David R McKenzie
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
- Charles Perkins Centre, The University of Sydney, Sydney, New South Wales 2006 Australia
- Sydney Nano Institute, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - Marcela M Bilek
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
- School of Biomedical Engineering, The University of Sydney, Sydney, New South Wales 2006 Australia
- Charles Perkins Centre, The University of Sydney, Sydney, New South Wales 2006 Australia
- Sydney Nano Institute, The University of Sydney, Sydney, New South Wales 2006 Australia
| |
Collapse
|
5
|
Johnson LM, Krovi SA, Li L, Girouard N, Demkovich ZR, Myers D, Creelman B, van der Straten A. Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP). Pharmaceutics 2019; 11:pharmaceutics11070315. [PMID: 31277461 PMCID: PMC6680758 DOI: 10.3390/pharmaceutics11070315] [Citation(s) in RCA: 55] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2019] [Revised: 06/21/2019] [Accepted: 06/29/2019] [Indexed: 11/29/2022] Open
Abstract
Long-acting (LA) HIV pre-exposure prophylaxis (PrEP) offers the potential to improve adherence by lowering the burden of daily or on-demand regimens of antiretroviral (ARV) drugs. This paper details the fabrication and in vitro performance of a subcutaneous and trocar-compatible implant for the LA delivery of tenofovir alafenamide (TAF). The reservoir-style implant comprises an extruded tube of a biodegradable polymer, poly(ε-caprolactone) (PCL), filled with a formulation of TAF and castor oil excipient. Parameters that affect the daily release rates of TAF are described, including the surface area of the implant, the thickness of the PCL tube walls (between 45 and 200 µm), and the properties of the PCL (e.g., crystallinity). In vitro studies show a linear relationship between daily release rates and surface area, demonstrating a membrane-controlled release mechanism from extruded PCL tubes. Release rates of TAF from the implant are inversely proportional to the wall thickness, with release rates between approximately 0.91 and 0.15 mg/day for 45 and 200 µm, respectively. The sustained release of TAF at 0.28 ± 0.06 mg/day over the course of 180 days in vitro was achieved. Progress in the development of this implant platform addresses the need for new biomedical approaches to the LA delivery of ARV drugs.
Collapse
Affiliation(s)
- Leah M Johnson
- Engineered Systems, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, NC 27709, USA.
| | - Sai Archana Krovi
- Engineered Systems, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, NC 27709, USA
| | - Linying Li
- Engineered Systems, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, NC 27709, USA
| | - Natalie Girouard
- Engineered Systems, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, NC 27709, USA
| | - Zach R Demkovich
- Women's Global Health Imperative, RTI International, 351 California Street, Suite 500, San Francisco, CA 94104, USA
| | - Daniel Myers
- PATH, 2201 Westlake Ave, Suite 200, Seattle, WA 98121, USA
| | - Ben Creelman
- PATH, 2201 Westlake Ave, Suite 200, Seattle, WA 98121, USA
| | - Ariane van der Straten
- Women's Global Health Imperative, RTI International, 351 California Street, Suite 500, San Francisco, CA 94104, USA
| |
Collapse
|
6
|
Mohan T, Nagaraj C, Nagy BM, Bračič M, Maver U, Olschewski A, Stana Kleinschek K, Kargl R. Nano- and Micropatterned Polycaprolactone Cellulose Composite Surfaces with Tunable Protein Adsorption, Fibrin Clot Formation, and Endothelial Cellular Response. Biomacromolecules 2019; 20:2327-2337. [PMID: 31070898 PMCID: PMC6750646 DOI: 10.1021/acs.biomac.9b00304] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2019] [Revised: 05/06/2019] [Indexed: 01/02/2023]
Abstract
This work describes the interaction of the human blood plasma proteins albumin, fibrinogen, and γ-globulins with micro- and nanopatterned polymer interfaces. Protein adsorption studies were correlated with the fibrin clotting time of human blood plasma and with the growth of primary human pulmonary artery endothelial cells (hECs) on these patterns. It was observed that blends of polycaprolactone (PCL) and trimethylsilyl-protected cellulose form various thin-film patterns during spin coating, depending on the mass ratio of the polymers in the spinning solutions. Vapor-phase acid-catalyzed deprotection preserves these patterns but yields interfaces that are composed of hydrophilic cellulose domains enclosed by hydrophobic PCL. The blood plasma proteins are repelled by the cellulose domains, allowing for a suggested selective protein deposition on the PCL domains. An inverse proportional correlation is observed between the amount of cellulose present in the films and the mass of irreversibly adsorbed proteins. This results in significantly increased fibrin clotting times and lower masses of deposited clots on cellulose-containing films as revealed by quartz crystal microbalance with dissipation measurements. Cell viability of hECs grown on these surfaces was directly correlated with higher protein adsorption and faster clot formation. The results show that presented patterned polymer composite surfaces allow for a controllable blood plasma protein coagulation and a significant biological response from hECs. It is proposed that this knowledge can be utilized in regenerative medicine, cell cultures, and artificial vascular grafts by a careful choice of polymers and patterns.
Collapse
Affiliation(s)
- Tamilselvan Mohan
- Laboratory
for Characterisation and Processing of Polymers, Faculty of Mechanical
Engineering, University of Maribor, Smetanova ulica17, 2000 Maribor, Slovenia
| | - Chandran Nagaraj
- Ludwig
Boltzmann Institute for Lung Vascular Research, Stiftingtalstrasse 24, 8010 Graz, Austria
| | - Bence M. Nagy
- Ludwig
Boltzmann Institute for Lung Vascular Research, Stiftingtalstrasse 24, 8010 Graz, Austria
| | - Matej Bračič
- Laboratory
for Characterisation and Processing of Polymers, Faculty of Mechanical
Engineering, University of Maribor, Smetanova ulica17, 2000 Maribor, Slovenia
| | - Uroš Maver
- Faculty
of Medicine, Institute of Biomedical Sciences, University of Maribor, Taborska Ulica 8, SI-2000 Maribor, Slovenia
| | - Andrea Olschewski
- Ludwig
Boltzmann Institute for Lung Vascular Research, Stiftingtalstrasse 24, 8010 Graz, Austria
- Chair
of Physiology, Otto Loewi Research Center, Neue Stiftingtalstraße 6/D05, 8010 Graz, Austria
| | - Karin Stana Kleinschek
- Laboratory
for Characterisation and Processing of Polymers, Faculty of Mechanical
Engineering, University of Maribor, Smetanova ulica17, 2000 Maribor, Slovenia
| | - Rupert Kargl
- Laboratory
for Characterisation and Processing of Polymers, Faculty of Mechanical
Engineering, University of Maribor, Smetanova ulica17, 2000 Maribor, Slovenia
| |
Collapse
|